Rigel Pharmaceuticals, Inc.
USD39.54
+0.50 (+1.28%)
CEO
Raul R. Rodriguez
IPO Date
2000-11-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$39.12
Prev. Close
$39.04
Day Low
$38.72
Day High
$39.88
52W Low
$18.24
52W High
$52.24
Market Cap
$0.73B
Volume
0.03M
| 16.9 |
| 31 Dec 2023 | FY | 93.9% | -21.5% | 87.6% | -21.4% | -2.11 | 1.86 | -10.1 |
| 31 Dec 2022 | FY | 98.5% | -48.7% | 430.2% | -43.6% | -3.05 | 1.78 | -4.4 |
| 31 Dec 2021 | FY | 99.3% | -12.0% | -59.0% | -10.7% | 1.01 | 2.43 | -25.2 |
| 31 Dec 2020 | FY | 99.2% | -27.4% | -87.4% | -26.9% | 1.15 | 2.18 | -19.9 |
| 31 Dec 2019 | FY | 98.5% | -112.2% | -123.7% | -45.1% | 0.67 | 2.04 | -5.4 |
| 31 Dec 2018 | FY | 99.4% | -158.3% | -64.1% | -50.7% | 0.00 | 4.94 | -5.2 |
| 31 Dec 2017 | FY | -931.9% | -1739.3% | -77.5% | -65.5% | 0.00 | 6.40 | -6.3 |
| 31 Dec 2016 | FY | -211.3% | -339.6% | -125.8% | -88.6% | 0.06 | 3.37 | -3.2 |
| 0.7 |
| 30 Sept 2025 | Q3 | 93.2% | 40.2% | 23.7% | 11.5% | 0.52 | 2.28 | 4.6 |
| 30 Jun 2025 | Q2 | 95.6% | 58.6% | 72.8% | 28.8% | 0.75 | 2.02 | 1.4 |
| 31 Mar 2025 | Q1 | 91.7% | 21.5% | 61.6% | 6.5% | 3.29 | 2.20 | 7.0 |
| 31 Dec 2024 | Q4 | 89.9% | 24.9% | 436.2% | 8.7% | 18.24 | 2.13 | 5.2 |
| 30 Sept 2024 | Q3 | 85.5% | 22.5% | -84.9% | 8.9% | -4.12 | 1.96 | 5.7 |
| 30 Jun 2024 | Q2 | 92.4% | -2.8% | 3.4% | -0.8% | -2.02 | 1.62 | -35.8 |
| 31 Mar 2024 | Q1 | 93.1% | -27.9% | 26.0% | -6.5% | -1.91 | 1.26 | -7.1 |
| 31 Dec 2023 | Q4 | 89.4% | 2.1% | -2.6% | 0.6% | -2.11 | 1.86 | 85.8 |